1-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)-3-[(1-propan-2-ylpyrazol-3-yl)sulfonimidoyl]urea
C21H25FN6O2S — CID 138532359
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)-3-[(1-propan-2-ylpyrazol-3-yl)sulfonimidoyl]urea
1-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)-3-[(1-propan-2-ylpyrazol-3-yl)sulfonimidoyl]urea (PubChem CID 138532359) has the molecular formula C21H25FN6O2S and a molecular weight of 444.54 g/mol. Its IUPAC name is 1-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)-3-[(1-propan-2-ylpyrazol-3-yl)sulfonimidoyl]urea.
Molecular Properties
| Compound Name | 1-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)-3-[(1-propan-2-ylpyrazol-3-yl)sulfonimidoyl]urea |
|---|---|
| PubChem CID | 138532359 |
| Molecular Formula | C21H25FN6O2S |
| Molecular Weight | 444.54 g/mol |
| Exact Mass | 444.17 |
| IUPAC Name | 1-(4-fluoro-2-propan-2-yl-6-pyridin-3-ylphenyl)-3-[(1-propan-2-ylpyrazol-3-yl)sulfonimidoyl]urea |
| SMILES | [H]N=S(=O)(NC(=O)Nc1c(-c2cccnc2)cc(F)cc1C(C)C)c1ccn(C(C)C)n1 |
| InChI | InChI=1S/C21H25FN6O2S/c1-13(2)17-10-16(22)11-18(15-6-5-8-24-12-15)20(17)25-21(29)27-31(23,30)19-7-9-28(26-19)14(3)4/h5-14H,1-4H3,(H3,23,25,27,29,30) |
| InChIKey | LQDJALHVJDCPRJ-UHFFFAOYSA-N |
| XLogP | 4.93 |
| TPSA | 112.76 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 444.54 |
| LogP ≤ 5 | 4.93 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138532359 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.